TY - JOUR
T1 - PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development
AU - Caruso, Breanna
AU - Weeder, Benjamin R.
AU - Thompson, Reid F.
AU - Moran, Amy E.
N1 - Publisher Copyright:
Copyright © 2024 The Authors.
PY - 2024/3
Y1 - 2024/3
N2 - Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1-deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1-deficient thymocytes produce elevated levels of IL-2, a Treg niche-limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection. ImmunoHorizons, 2024, 8: 281-294.
AB - Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1-deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1-deficient thymocytes produce elevated levels of IL-2, a Treg niche-limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection. ImmunoHorizons, 2024, 8: 281-294.
UR - http://www.scopus.com/inward/record.url?scp=85189078604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85189078604&partnerID=8YFLogxK
U2 - 10.4049/immunohorizons.2300079
DO - 10.4049/immunohorizons.2300079
M3 - Article
C2 - 38551395
AN - SCOPUS:85189078604
SN - 2573-7732
VL - 8
SP - 281
EP - 294
JO - ImmunoHorizons
JF - ImmunoHorizons
IS - 3
ER -